Showing 721-730 of 7174 results for "".
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-counterfeit-botox-cases-widen-new-hs-treatment-approved-europe/24419/In this episode of DermwireTV, the use of counterfeit Botox continues to widen; a first-of-its-kind drug is approved in Europe for hidradenitis suppurativa; and the PA Perspective series provides tips for training and onboarding in a new practice.Physicians Have a Duty to Disobey
https://practicaldermatology.com/topics/practice-management/physicians-have-a-duty-to-disobey/24208/When I was in high school in the 1970s, we were required to read Henry David Thoreau’s essay, Civil Disobedience. We were taught that when confronted with something clearly wrong or unethical, it is our duty to stand up against it—even if it means not abiding by unjust laws or rules. We were to liveIntergenerational Dermatology: Two Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-two-generations-of-dermatologists-reflect-on-the-field-2/23937/With Heidi A. Waldorf, MD, and Donald S. Waldorf, MDDataDerm Update
https://practicaldermatology.com/topics/practice-management/dataderm-update/23891/Joining can do a lot for your practice and patients.How Exceptional Reception Design Can Maximize Sales
https://practicaldermatology.com/topics/practice-management/how-exceptional-reception-design-can-maximize-sales/23779/Many factors determine the impact of this generally small but important space.Cognitive Bias And The Art of Doctoring
https://practicaldermatology.com/topics/practice-management/cognitive-bias-and-the-art-of-doctoring/23680/Rethinking the approach to diagnosis may reduce errors and improve patient interactions.DermWireTV: Skyrizi for PsA; Toxins and Wound Healing at Maui Derm; SDDS Registration
https://practicaldermatology.com/topics/psoriasis/skyrizi-for-psa-toxins-and-wound-healing-at-maui-derm-sdds-registration-dermwiretv/20057/Skyrizi (AbbVie) is now approved for the treatment of adults with active psoriatic arthritis. Michael Gold, MD was among the speakers who offered updates on cosmetic trends as well as medical care at Maui Dermatology for Dermatologists last week. He spoke about high-dose neurotoxins. Robert KirsnerEmail Marketing: Why and How To Use It For Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/email-marketing-why-and-how-to-use-it-for-your-dermatology-practice/23641/Text and social media have not displaced traditional email marketing strategies.Disability Income Insurance: What Every Young Dermatologist Needs to Know
https://practicaldermatology.com/topics/practice-management/disability-income-insurance-what-every-young-dermatologist-needs-to-know/23597/Getting disability income insurance at an early age may offer lower rates and long-term peace of mind.DermWireTV: Sanofi Genzyme & Regeneron Global AD Report; Hydroquinone; Pfizer NDA; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-sanofi-genzyme-regeneron-global-ad-report-hydroquinone-pfizer-nda-vcs/19868/The “Improving Quality of Care in AD” report, commissioned and funded by Sanofi Genzyme & Regeneron and completed by KPMG, debuts at the annual meeting of the EADV. Changes to FDA regulations implemented as part of the CARES Act limit access to hydroquinone. This year’s Virtual Vegas Cosmetic Su